Overall, our combined results suggest that DRD2 dependence is of functional consequence to leukemic progenitor activity and that dopaminergic signaling presents a tunable axis for malignant transformation in a subset of DRD2+ AML patients. This evidence concerns the gene DRD2 and acute myeloid leukemia.